Clopidogrel is an anti-platelet drug, of the thienopyridine class, which is licensed for the secondary prophylaxis of atherosclerotic complications in patients with:
The dose is 75 mg per day.
The principal side-effect is haemorrhage, including:
There may be gastrointestinal upset.
Maximal inhibition of platelet aggregation is achieved after 4-7 days with clopidogrel 75 mg per day (1).
The summary of product characteristics should be consulted before prescribing this drug.
Last reviewed 04/2021